The effects of coxib formulary restrictions on analgesic use and cost: Regional evidence from Canada

Abstract Background Public insurance plans for pharmaceuticals in Canada differ substantially across provinces in the conditions under which pharmaceuticals are reimbursed. Coxibs provide a good example. Québec had no restrictions on reimbursement for these drugs. Ontario required physicians to subm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Health policy (Amsterdam) 2007-11, Vol.84 (1), p.1-13
Hauptverfasser:	Marshall, Deborah A, Willison, Donald J, Grootendorst, Paul, LeLorier, Jacques, Maclure, Malcolm, Kulin, Nathalie A, Sheehy, Odile E, Warren, Leanne, Sykora, Kathy, Rahme, Elham
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration Administrative restrictions Analgesics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Canada Comparative analysis Cox-2 inhibitors Coxibs Cyclooxygenase 2 Inhibitors - economics Cyclooxygenase 2 Inhibitors - therapeutic use Drug diffusion Evidence-Based Medicine Formularies as Topic Health administration Health costs Health insurance Health policy Humans Internal Medicine Limited use policy National Health Programs - organization & administration Non-steroidal anti-inflammatory drugs Non-steroidal anti-inflammatory drugs Coxibs Cox-2 inhibitors Health policy Drug diffusion Administrative restrictions Special authority Limited use policy Analgesics Nonsteroidal antiinflammatory drugs Organizational Policy Pharmaceuticals Prescriptions Regulation Reimbursement Reimbursement Mechanisms - organization & administration Retrospective Studies Special authority Utility measurement
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!